Skip to content

In the BioHarmony Drug Report Database


Jublia (efinaconazole) is a small molecule pharmaceutical. Efinaconazole was first approved as Jublia on 2014-06-06. It is used to treat mycoses and onychomycosis in the USA. Jublia's patents are valid until 2035-04-25 (FDA).
Trade Name Jublia
Common Name Efinaconazole
Indication mycoses, onychomycosis
Drug Class Systemic antifungals (miconazole type); Fc fusion protein
Get full access now